Science Mission - Gaucher Disease http://sciencemission.com/site/index.php? page=news&type=view&id=presentations%2Fgaucher-disease_2&filter=23 | Facebook
International Gaucher Alliance - Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, is currently conducting a Phase 1/2 clinical trial, called PROVIDE, assessing the safety and efficacy of PR001,
![Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation | BMC Medical Genetics | Full Text Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation | BMC Medical Genetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12881-019-0759-1/MediaObjects/12881_2019_759_Fig2_HTML.png)